Related references
Note: Only part of the references are listed.Bordetella Bsp22 forms a filamentous type III secretion system tip complex and is immunoprotective in vitro and in vivo
Bob Medhekar et al.
MOLECULAR MICROBIOLOGY (2009)
Toll-Like Receptor 6 Drives Differentiation of Tolerogenic Dendritic Cells and Contributes to LcrV-Mediated Plague Pathogenesis
R. William DePaolo et al.
CELL HOST & MICROBE (2008)
Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses
Neil K. Fennelly et al.
INFECTION AND IMMUNITY (2008)
New insights into NF-kappa B regulation and function
Shao-Cong Sun et al.
TRENDS IN IMMUNOLOGY (2008)
LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms
Hugues Chanteux et al.
RESPIRATORY RESEARCH (2007)
Evaluation of the role of LcrV-Toll-Like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis
Kimberly Pouliot et al.
INFECTION AND IMMUNITY (2007)
The phosphothreonine lyase activity of a bacterial type III effector family
Hongtao Li et al.
SCIENCE (2007)
An injected bacterial effector targets chromatin access for transcription factor NF-κB to alter transcription of host genes involved in immune responses
Laurence Arbibe et al.
NATURE IMMUNOLOGY (2007)
Pertussis resurgence: Diagnosis, treatment, prevention, and beyond
Sarah E. Raguckas et al.
PHARMACOTHERAPY (2007)
Protein delivery into eukaryotic cells by type III secretion machines
Jorge E. Galan et al.
NATURE (2006)
NF-κB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages
Shanjin Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
BopC is a novel type III effector secreted by Bordetella bronchiseptica and has a critical role in type III-dependent necrotic cell death
A Kuwae et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance
MR Pilione et al.
INFECTION AND IMMUNITY (2006)
A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence
A Sing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles
CA Mueller et al.
SCIENCE (2005)
Bordetella type III secretion modulates dendritic cell migration resulting in immunosuppression and bacterial persistence
JA Skinner et al.
JOURNAL OF IMMUNOLOGY (2005)
A genome-wide screen identifies a Bordetella type III secretion effector and candidate effectors in other species
EM Panina et al.
MOLECULAR MICROBIOLOGY (2005)
The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes
DW Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies
S Mattoo et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Downregulation of mitogen-activated protein kinases by the Bordetella bronchiseptica type III secretion system leads to attenuated nonclassical macrophage activation
A Reissinger et al.
INFECTION AND IMMUNITY (2005)
Bordetella type III secretion and adenylate cyclase toxin synergize to drive dendritic cells into a semimature state
JA Skinner et al.
JOURNAL OF IMMUNOLOGY (2004)
Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappa B activity: a role for p50
F Driessler et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
The type III secreted protein BopD in Bordetella bronchiseptica is complexed with BopB for pore formation on the host plasma membrane
H Nogawa et al.
JOURNAL OF BACTERIOLOGY (2004)
Bordetella pertussis protein pertactin induces type-specific antibodies:: One possible explanation for the emergence of antigenic variants?
QS He et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
BopB is a type III secreted protein in Bordetella bronchiseptica and is required for cytotoxicity against cultured mammalian cells
A Kuwae et al.
CELLULAR MICROBIOLOGY (2003)
Molecular epidemiology of feline bordetellosis in two animal shelters in California, USA
JE Foley et al.
PREVENTIVE VETERINARY MEDICINE (2002)
Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells:: A novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis
P McGuirk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
p38-dependent marking of inflammatory genes for increased NF-kappa B recruitment
S Saccani et al.
NATURE IMMUNOLOGY (2002)
Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland
A Gzyl et al.
VACCINE (2001)
Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure
K Sekiya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Phagocytosed Bordetella pertussis fails to survive in human neutrophils
DH Lenz et al.
INFECTION AND IMMUNITY (2000)
Modulation of host immune responses, induction of apoptosis and inhibition of NF-kappa B activation by the Bordetella type III secretion system
MH Yuk et al.
MOLECULAR MICROBIOLOGY (2000)
Share Paper
